[Recommendations of the European League Against Rheumatism (EULAR) for the treatment of "large-vessel vasculitides"]

Z Rheumatol. 2009 May;68(3):260, 262-3. doi: 10.1007/s00393-008-0387-1.
[Article in German]
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Aspirin / adverse effects
  • Aspirin / therapeutic use
  • Etanercept
  • Europe
  • Evidence-Based Medicine*
  • Giant Cell Arteritis / diagnosis
  • Giant Cell Arteritis / drug therapy*
  • Glucocorticoids / adverse effects
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunoglobulin G / adverse effects
  • Immunoglobulin G / therapeutic use
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Takayasu Arteritis / diagnosis
  • Takayasu Arteritis / drug therapy*

Substances

  • Antirheumatic Agents
  • Glucocorticoids
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Etanercept
  • Aspirin